Chris Lau

Allergan (AGN) Will Bottom at $160.
8 november

AGN's down after losing patent rights to Relistor. Stock will bottom at $160.

$AGN, ALLERGAN Inc / H1

Related: 

  • VRX bottomed.
  • TEVA is facing selling pressure.
  • MYL is the best of the bunch.
  • ENDP is stabilising.

Login now and Agree or disagree.

Answered:
3 people

Allergan (AGN) Will Bottom at $160.

Untill the end of voting

3 people answered this forecast.

Would you like to know how many people agreed or disagreed? Vote.